Non-linear vs linear strength training for adults with type 2 diabetes

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

In this randomized trial, adults with type 2 diabetes are assigned to non-linear periodization strength training, linear periodization strength training, or usual care for 8 weeks, three sessions per week. The study will measure exercise capacity, muscle strength, body composition, quality of life, and metabolic parameters before and after the program. The goal is to determine which periodization approach, if any, provides the greatest benefits for physical function and metabolic health in this population. Safety criteria exclude individuals with advanced diabetic complications and certain cardiovascular or respiratory conditions. Baskent University Hospital serves as the study site, with Baskent University as the lead sponsor.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Adults aged between 18 to 65 years
* Diagnosis of Type 2 Diabetes Mellitus (T2DM)
* Not having participated in any structured exercise program within the last 6 months
* Willingness to participate in the study and provide written informed consent

Exclusion Criteria:

* Presence of nephropathy, retinopathy, or peripheral neuropathy
* Presence of neurological, cognitive, or orthopedic disorders that may affect outcome measurements
* Severe respiratory disease (Forced Expiratory Volume in the first second \[FEV1\] \<35% or Forced Vital Capacity \[FVC\] \<50%)
* Presence of ischemic heart disease or peripheral arterial disease
* History of any cardiovascular event within the last 6 months
* Current malignancy

Where it's running

• Baskent University Hospital
  Ankara, Ankara, Turkey (Türkiye) Recruiting

Study contacts

• Principal investigator: Neslihan Duruturk, PhD — Baskent University
• Study coordinator: Ayşegül Erkoç, PT
• Email: erkcaysegl@gmail.com
• Phone: +90 553-301-36-73

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Acute Blood Flow Restriction Walking in Type 2 Diabetes

  This study tests whether adding blood flow restriction to treadmill walking affects immune cells in adults with type 2 diabetes.

  Recruiting University of British Columbia · Kelowna, British Columbia · NCT07928531

• Continuous Glucose Monitoring in Type 2 Diabetes Not on Insulin

  This study tests whether using a continuous glucose monitoring system helps people with type 2 diabetes who aren’t using insulin to improve blood sugar control and quality of life.

  Recruiting Medical University of Bialystok · Bialystok · NCT07919236

• Differentiating heart disease in autoimmune vs. type 2 diabetes

  This study tests whether adult-onset autoimmune diabetes (AID/LADA) and type 2 diabetes (T2D) differ in how diabetic heart disease develops, using advanced heart imaging in people with AID, T2D, and healthy controls.

  Recruiting University of Roma La Sapienza · Rome, Roma · NCT07911007

• Lifestyle Metabotype Study B: Understanding Personalized Glucose Responses

  This study tests how lifestyle, metabolism, and brain energy use relate to each person’s blood sugar response after meals, across people with and without prediabetes or type 2 diabetes.

  Recruiting at 2 sites German Institute of Human Nutrition · Berlin and 1 other locations · NCT07888257

• Lifestyle Metabotype Study: How Daily Habits Shape Blood Sugar

  This observational study tests whether personal lifestyle and biological factors can predict how a person’s blood sugar responds after meals.

  Recruiting German Institute of Human Nutrition · Potsdam, Potsdam-Rehbrücke · NCT07868601

• Switching to Zenagamtide From Tirzepatide in Adults With Overweight or Obesity With or Without Type 2 Diabetes

  This study tests whether adults who are overweight or have obesity (with or without type 2 diabetes) can switch from tirzepatide to a new treatment called zenagamtide to find a tolerable dose.

  Recruiting at 2 sites Phase 1 Novo Nordisk A/S · Glendale, California and 1 other locations · NCT07868354

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.